Tuesday that revenue of its Hepatitis C drug gilead Sciences reported, Sovaldi, fell 20 percent from the last quarter nearly. World News & Analysis
Read More »Tuesday that revenue of its Hepatitis C drug gilead Sciences reported, Sovaldi, fell 20 percent from the last quarter nearly. World News & Analysis
Read More »